Onyx Pharmaceuticals, Inc. (ONXX) Reports Stronger-Than-Expected Q4 Results
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Price: $124.70 --0%
Financial Fact:
Loss from operations: -47.53M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Loss from operations: -47.53M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) reported Q4 EPS of $1.50, $0.07 better than the analyst estimate of $1.43. Revenue for the quarter came in at $237 million versus the consensus estimate of $213.24 million.
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
For earnings history and earnings-related data on Onyx Pharmaceuticals, Inc. (ONXX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- Deutsche Bank monitors UK auto sales as Chinese exports grow
- Advance Auto Parts (AAP) PT Lowered to $43 at Truist Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
